Literature DB >> 3484506

Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.

J R Schreiber, V Barrus, K L Cates, G R Siber.   

Abstract

Antibody to the capsular polysaccharide (CP) of Haemophilus influenzae b (Hib) is bactericidal, opsonic, and protective. Minimum protective levels of primarily IgG antibody to Hib CP, calculated from passive immunization studies, have been found to be approximately .06-.15 microgram/ml of serum. The human response to antigenic challenge with the Hib capsule, however, includes production of antibody to Hib CP of different isotypes whose function against Hib is unclear. In order to characterize the function of antibody to Hib CP of different isotypes, we purified human IgG, IgM, and IgA from the serum of an adult donor who had been previously immunized with purified Hib CP vaccine. The globulin preparations were greater than 99% isotypically pure, contained large quantities of anticapsular antibody, and differed in function against Hib. IgG antibody to Hib CP was bactericidal and opsonic for human polymorphonuclear leukocytes (PMNLs) in the presence of complement and protective in infant rats. IgM, although more bactericidal than IgG (P less than .01) and equally protective in rats, opsonized Hib poorly for PMNLs. IgA was not bactericidal or opsonic and did not prevent bacteremia and meningitis in rats challenged with Hib. We conclude that antibody directed against the capsule of Hib differs in antibacterial function depending on class. These data may be important to acurately estimate minimum protective levels of anticapsular antibody after vaccination or natural infection and may have implications for the manner in which the host clears Hib from the circulation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484506     DOI: 10.1093/infdis/153.1.8

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Immune response to Haemophilus influenzae type b vaccination in patients with chronic renal failure.

Authors:  Nicole Hawdon; Eli B Nix; Raymond S W Tsang; Garry Ferroni; William G McCready; Marina Ulanova
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

Review 2.  Effectiveness of Haemophilus influenzae type b vaccines.

Authors:  D M Stieb; H H Frayha; A D Oxman; H S Shannon; B G Hutchison; F S Crombie
Journal:  CMAJ       Date:  1990-04-01       Impact factor: 8.262

3.  Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.

Authors:  P A Shurin; G S Giebink; D L Wegman; D Ambrosino; J Rholl; M Overman; T Bauer; G R Siber
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

4.  Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Authors:  Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

5.  Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations.

Authors:  Saeyoung Park; Moon H Nahm
Journal:  Infect Immun       Date:  2010-11-01       Impact factor: 3.441

6.  Complement component 3 binding to Haemophilus influenzae type b in the presence of anticapsular and anti-outer membrane antibodies.

Authors:  S V Hetherington; C C Patrick
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

7.  Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.

Authors:  T Barington; L Juul; A Gyhrs; C Heilmann
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls.

Authors:  M A Avanzini; A M Carrà; R Maccario; M Zecca; G Zecca; A Pession; P Comoli; M Bozzola; A Prete; R Esposito; F Bonetti; F Locatelli
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

9.  Anti-idiotype vaccines for immunity to bacterial polysaccharides: induction of functional antibodies to polysaccharide antigens of Pseudomonas aeruginosa.

Authors:  J R Schreiber
Journal:  Springer Semin Immunopathol       Date:  1993

10.  Role of complement in mouse macrophage binding of Haemophilus influenzae type b.

Authors:  G J Noel; D M Mosser; P J Edelson
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.